Effect of Liraglutide, Metformin, and Gliclazide on Body Composition in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease-A Randomised Trial

被引：0
|
作者：
Feng, Wenhuan
Bi, Yan
Li, Ping
Yin, Tingting
Gao, Caixia
Shen, Shanmei
Gao, Lijun
Jiang, Can
Zhu, Dalong
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1344-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
    Ohki, Takamasa
    Isogawa, Akihiro
    Iwamoto, Masahiko
    Ohsugi, Mitsuru
    Yoshida, Haruhiko
    Toda, Nobuo
    Tagawa, Kazumi
    Omata, Masao
    Koike, Kazuhiko
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [22] Plasma Fatty Acid Composition Is Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients
    Higa, Mariko
    Ichijo, Takamasa
    DIABETES, 2022, 71
  • [23] Effect of body mass index on nonalcoholic fatty liver disease in patients
    Frantzides, CT
    Carlson, MA
    Moore, RE
    Zografakis, JG
    Madan, AK
    Puumala, S
    Keshavarzian, A
    JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (07) : 849 - 855
  • [24] Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Gramlich, Terry
    Matteoni, Christi A.
    Boparai, Navdeep
    Mccullough, Arthur J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 262 - 265
  • [25] The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease
    Song, Do Seon
    GUT AND LIVER, 2024, 18 (04) : 562 - 563
  • [26] Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease
    Puchakayala, Bharat K.
    Verma, Siddharth
    Kanwar, Pushpjeet
    Hart, John
    Sanivarapu, Raghavendra R.
    Mohanty, Smruti R.
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (25) : 2610 - 2618
  • [27] Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic(type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease
    Bharat K Puchakayala
    Siddharth Verma
    Pushpjeet Kanwar
    John Hart
    Raghavendra R Sanivarapu
    Smruti R Mohanty
    World Journal of Hepatology, 2015, (25) : 2610 - 2618
  • [28] Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
    Ying, Xing
    Zheng, Rongjiong
    Kahaer, Mayila
    Jiang, Chunhui
    Wulasihan, Muhuyati
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [29] Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial
    El-Kady, Rasha R.
    Ali, Amani K.
    El Wakeel, Lamia M.
    Sabri, Nagwa A.
    Shawki, May A.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [30] Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
    Targher, Giovanni
    Bertolini, Lorenzo
    Padovani, Roberto
    Rodella, Stefano
    Tessari, Roberto
    Zenari, Luciano
    Day, Christopher
    Arcaro, Guido
    DIABETES CARE, 2007, 30 (05) : 1212 - 1218
12345